CClinicalTrials.gg
Not yet recruitingNCT06375096Updated Apr 19, 2024

Bone Mineral Density in Children With Graves' Disease

An observational study in Bone Density, Low and Bone Mineral Density in Children With Graves' Disease, sponsored by Assiut University. Not yet recruiting. Open to participants aged 2 Years to 18 Years. Per ClinicalTrials.gov, last updated 2024-04-19.

Sponsored by Assiut University · Observational

From the registry’s dates

  • Primary completion was expected by Jun 2025, 1 year 3 months ago, but the record still lists the study as not yet recruiting.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
100
Ages
2 Years to 18 Years
Sex
All
01

Study summary

to evaluate bone mineral density in children with graves' disease

02

Conditions studied

  • Bone Density, Low
  • Bone Mineral Density in Children With Graves' Disease
03

In context

Bone Diseases, Metabolic

470 studies on the registry are indexed under Bone Diseases, Metabolic; 71 are open to participants now.

This study's planned enrollment of 100 is above the median of 81 across 103 observational studies indexed under Bone Diseases, Metabolic.

Browse Bone Diseases, Metabolic studies →

Lead sponsor

Assiut University is the lead sponsor of 4,901 studies on the registry; 2,098 are open to participants now.

Of its 13 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
2 Years to 18 Years
Sexes eligible
All
Sampling method
Non-probability sample

Study population

children diagnosed with graves' disease, more than 2 years and less than 18 years

Inclusion criteria

  • age at enrollment ≥2 years to \< 18 years
  • both sexes
  • the patients should be diagnosed with graves'

Exclusion criteria

Exclusion Criteria:

  • patients less than 2 years
  • patients more than 18 years
  • Controlled GD patients on antithyroid
  • patients with other endocrine diseases
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
100 participants (estimated)
Patient registry
No

Interventions

  • Otherevaluate bone mineral density

    observation effect of graves' in bone mineral density in children

06

What researchers measure

Primary outcomes

  1. bone mineral density

    measure bone mineral density in children diagnosed with graves' disease, to evaluate the effect of the disease on it and the effect of antithyroid medication after that

    Time frame: 1 month

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 19, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06375096
Lead sponsor
Assiut University
Responsible party
Hadeer Youssef Mahmoud Nasr (Bone mineral density in children diagnosed with graves' disease, Assiut University) — Principal investigator
First posted
Apr 19, 2024
Start date
Jun 25, 2024 (estimated)
Primary completion
Jun 25, 2025 (estimated)
Completion
Jun 25, 2025 (estimated)
Last update
Apr 19, 2024

Study contacts

Hadeer Youssef Mahmoud
Contact
hadeeryoussef754@gmail.com
01110548137

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Apr 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion